🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6194547

ETS2 repressor factor (ERF)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194390

Procedure to block the replication of reverse transcriptase dependent viruses by the use o

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194388

Immunomodulatory oligonucleotides

The United States of America · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6193982

Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a m

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6193949

Method of sire selection using naloxone challenge tests and kits thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190859

Method and kit for detection of dengue virus

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190656

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6187775

Acridone-derived compounds useful as antineoplastic and antiretroviral agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6187745

Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6187306

Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of usin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184339

High strength polymeric networks derived from (meth) acrylate resins with organofluorine c

The United States of America as represented by the Secretary of the Commerce · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184246

Inhibition of cytokine production by polymethoxylated flavones

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6184024

Chimeric and/or growth-restricted flaviviruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6183752

Restenosis/atherosclerosis diagnosis, prophylaxis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6180110

Attenuated hepatitis a virus vaccine which grows in MRC-5 cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6177534

Silylated resins and the synthesis thereof

Government of the United States of America, as represented by the Secretary of Commerce · Granted Tue Jan 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6177415

Bacteriohopanetetrol and related compounds useful for modulation of lipoxygenase activity

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6174862

Neurotrophic peptides of activity dependent neurotrophic factor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6174666

Method of eliminating inhibitory/instability regions from mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6172070

Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6171596

Oligomeric HIV-1 envelope glycoproteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165781

Modified adeno-associated virus vector capable of expression from a novel promoter

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6165460

Generation of immune responses to prostate-specific antigen (PSA)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6162897

17q-linked breast and ovarian cancer susceptibility gene

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired